BioPharmSignal logoBioPharmSignal

Biotech News

Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026

Neuronetics (STIM)NeuroneticsCompany update

MALVERN, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will

Related news

STIMNeuronetics2026-08-03 12:00 EST

Neuronetics and Jorey Chernett Announce Shared Vision

STIMNeuronetics2026-07-31 21:00 EST

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AORTArtivion2026-06-10 20:10 EST

Artivion to Participate in the 2026 Truist Securities MedTech Conference

LMATLeMaitre Vascular2026-08-06 21:15 EST

LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

MMSIMerit Medical2026-08-05 16:00 EST

Merit Medical to Participate in Upcoming Investors Conferences in August

XTNTXtant Medical2026-08-04 20:05 EST

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

AORTArtivion2026-07-28 20:10 EST

Artivion to Participate in Upcoming Investor Conferences

DCTHDelcath Systems2026-07-28 20:01 EST

Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference

ANGOAngioDynamics2026-07-28 12:30 EST

AngioDynamics to Participate in Upcoming Investor Conferences

ATRCAtriCure2026-07-27 12:00 EST

AtriCure to Participate at Upcoming Investor Conferences

View all latest news

Neuronetics

Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy. NeuroStar Advanced Therapy NeuroStar uses...

Recent company news

STIMNeuronetics2026-08-03 12:00 EST

Neuronetics and Jorey Chernett Announce Shared Vision

STIMNeuronetics2026-07-31 21:00 EST

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

STIMNeuronetics2026-07-28 12:32 EST

Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

STIMNeuronetics2026-07-28 12:30 EST

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

STIMNeuronetics2026-07-20 20:05 EST

Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Stock data

Close
2.25 USD
Market cap
108.56M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States